Logo image of PLMK

PLUM ACQUISITION CORP IV (PLMK) Stock Fundamental Analysis

NASDAQ:PLMK - Nasdaq - KYG7134A1040 - Common Stock - Currency: USD

10.26  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PLMK. PLMK was compared to 0 industry peers in the Unkown industry. While PLMK seems to be doing ok healthwise, there are quite some concerns on its profitability. PLMK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PLMK had positive earnings in the past year.
PLMK Yearly Net Income VS EBIT VS OCF VS FCFPLMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -20K -40K -60K -80K

1.2 Ratios

Industry RankSector Rank
ROA 0.62%
ROE 0.64%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLMK Yearly ROA, ROE, ROICPLMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 50 -50 100

1.3 Margins

PLMK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PLMK Yearly Profit, Operating, Gross MarginsPLMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

PLMK Yearly Shares OutstandingPLMK Yearly Shares OutstandingYearly Shares Outstanding 2024 1M 2M 3M 4M
PLMK Yearly Total Debt VS Total AssetsPLMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 100K 200K 300K 400K

2.2 Solvency

PLMK has an Altman-Z score of 21.02. This indicates that PLMK is financially healthy and has little risk of bankruptcy at the moment.
PLMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.02
ROIC/WACCN/A
WACCN/A
PLMK Yearly LT Debt VS Equity VS FCFPLMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 -20K -40K -60K

2.3 Liquidity

PLMK has a Current Ratio of 4.17. This indicates that PLMK is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 4.17 indicates that PLMK has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.17
Quick Ratio 4.17
PLMK Yearly Current Assets VS Current LiabilitesPLMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 100K 200K 300K 400K 500K

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 171.00, which means the current valuation is very expensive for PLMK.
The average S&P500 Price/Earnings ratio is at 26.31. PLMK is valued rather expensively when compared to this.
Industry RankSector Rank
PE 171
Fwd PE N/A
PLMK Price Earnings VS Forward Price EarningsPLMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PLMK Per share dataPLMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PLMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLUM ACQUISITION CORP IV

NASDAQ:PLMK (6/11/2025, 8:10:18 PM)

10.26

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-15 2025-05-15
Earnings (Next)N/A N/A
Inst Owners79.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap248.70M
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 171
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.46
P/tB 1.46
EV/EBITDA N/A
EPS(TTM)0.06
EY0.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.01
TBVpS7.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.62%
ROE 0.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.17
Quick Ratio 4.17
Altman-Z 21.02
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A